BR9702328A - Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina - Google Patents
Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosinaInfo
- Publication number
- BR9702328A BR9702328A BR9702328A BR9702328A BR9702328A BR 9702328 A BR9702328 A BR 9702328A BR 9702328 A BR9702328 A BR 9702328A BR 9702328 A BR9702328 A BR 9702328A BR 9702328 A BR9702328 A BR 9702328A
- Authority
- BR
- Brazil
- Prior art keywords
- bicyclic
- tyrosine kinase
- kinase inhibitors
- aralkylaminopyrimidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613021.6A GB9613021D0 (en) | 1996-06-21 | 1996-06-21 | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
PCT/EP1997/002965 WO1997049689A1 (en) | 1996-06-21 | 1997-06-03 | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9702328A true BR9702328A (pt) | 1999-07-20 |
Family
ID=10795666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9702328A BR9702328A (pt) | 1996-06-21 | 1997-06-03 | Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina |
Country Status (20)
Country | Link |
---|---|
US (1) | US6057326A (pt) |
EP (1) | EP0853616B1 (pt) |
JP (1) | JPH11511761A (pt) |
KR (1) | KR19990043993A (pt) |
CN (1) | CN1198158A (pt) |
AR (1) | AR008614A1 (pt) |
AT (1) | ATE205836T1 (pt) |
AU (1) | AU3094197A (pt) |
BR (1) | BR9702328A (pt) |
CA (1) | CA2228492C (pt) |
DE (1) | DE69706823T2 (pt) |
EA (1) | EA199800215A1 (pt) |
ES (1) | ES2165061T3 (pt) |
GB (1) | GB9613021D0 (pt) |
HU (1) | HUP9902026A3 (pt) |
IL (1) | IL123124A0 (pt) |
NO (1) | NO980718L (pt) |
PL (1) | PL325122A1 (pt) |
WO (1) | WO1997049689A1 (pt) |
ZA (1) | ZA975380B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6347480B1 (en) * | 1997-07-07 | 2002-02-19 | Southpac Trust International, Inc. | Method for wrapping a floral grouping with a sheet of material constructed of paper and having printed and embossed patterns thereon |
SK285141B6 (sk) | 1996-02-13 | 2006-07-07 | Astrazeneca Uk Limited | Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje |
EP0885198B1 (en) | 1996-03-05 | 2001-12-19 | AstraZeneca AB | 4-anilinoquinazoline derivatives |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
US6608060B1 (en) | 1996-12-18 | 2003-08-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US5945418A (en) * | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
AU1071301A (en) * | 1999-11-01 | 2001-05-14 | Eli Lilly And Company | Pharmaceutical compounds |
ES2306306T3 (es) | 1999-11-05 | 2008-11-01 | Astrazeneca Ab | Nuevos derivados de quinazolina. |
WO2003009852A1 (en) * | 2001-07-24 | 2003-02-06 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
KR100468352B1 (ko) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물 |
US20050124637A1 (en) * | 2003-08-15 | 2005-06-09 | Irm Llc | Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
CA2557433C (en) * | 2004-02-19 | 2013-05-14 | Rexahn Corporation | Quinazoline derivatives and therapeutic use thereof |
US7151176B2 (en) * | 2004-10-21 | 2006-12-19 | Bristol-Myers Squibb Company | Pyrrolotriazine compounds |
WO2006104971A1 (en) * | 2005-03-28 | 2006-10-05 | Bristol-Myers Squibb Company | Atp competitive kinase inhibitors |
KR101703941B1 (ko) * | 2008-11-10 | 2017-02-07 | 내셔날 헬스 리서치 인스티튜트 | 티로신 키나아제 억제제로서의 접합 이환 및 삼환 피리미딘 화합물 |
UA110113C2 (xx) * | 2010-07-29 | 2015-11-25 | Біциклічні азагетероциклічні карбоксаміди | |
JP5961187B2 (ja) * | 2010-12-20 | 2016-08-02 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Pi3k阻害剤としてのn−(1−(置換フェニル)エチル)−9h−プリン−6−アミン |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89028A0 (en) * | 1988-01-29 | 1989-08-15 | Lilly Co Eli | Quinoline,quinazoline and cinnoline derivatives |
ZA902280B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor agents |
JP2762430B2 (ja) * | 1991-01-18 | 1998-06-04 | 宇部興産株式会社 | アラルキルアミノピリミジン類の製法 |
US5710158A (en) * | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
JPH06172321A (ja) * | 1992-10-08 | 1994-06-21 | Agro Kanesho Co Ltd | 置換アミノピリミジン誘導体、その製造法及びそれを有効成分とする有害生物駆除剤 |
GB9313638D0 (en) * | 1993-07-01 | 1993-08-18 | Erba Carlo Spa | Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
GB9326136D0 (en) * | 1993-12-22 | 1994-02-23 | Erba Carlo Spa | Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
GB9406137D0 (en) * | 1994-03-28 | 1994-05-18 | Erba Carlo Spa | N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation |
GB9412719D0 (en) * | 1994-06-24 | 1994-08-17 | Erba Carlo Spa | Substituted azaindolylidene compounds and process for their preparation |
GB9423997D0 (en) * | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
-
1996
- 1996-06-21 GB GBGB9613021.6A patent/GB9613021D0/en active Pending
-
1997
- 1997-06-03 BR BR9702328A patent/BR9702328A/pt not_active Application Discontinuation
- 1997-06-03 JP JP10502193A patent/JPH11511761A/ja not_active Ceased
- 1997-06-03 KR KR1019980701225A patent/KR19990043993A/ko not_active Application Discontinuation
- 1997-06-03 WO PCT/EP1997/002965 patent/WO1997049689A1/en not_active Application Discontinuation
- 1997-06-03 AU AU30941/97A patent/AU3094197A/en not_active Abandoned
- 1997-06-03 DE DE69706823T patent/DE69706823T2/de not_active Expired - Fee Related
- 1997-06-03 CN CN97190942A patent/CN1198158A/zh active Pending
- 1997-06-03 CA CA002228492A patent/CA2228492C/en not_active Expired - Fee Related
- 1997-06-03 EP EP97925987A patent/EP0853616B1/en not_active Expired - Lifetime
- 1997-06-03 US US09/000,238 patent/US6057326A/en not_active Expired - Fee Related
- 1997-06-03 IL IL12312497A patent/IL123124A0/xx unknown
- 1997-06-03 HU HU9902026A patent/HUP9902026A3/hu unknown
- 1997-06-03 EA EA199800215A patent/EA199800215A1/ru unknown
- 1997-06-03 PL PL97325122A patent/PL325122A1/xx unknown
- 1997-06-03 ES ES97925987T patent/ES2165061T3/es not_active Expired - Lifetime
- 1997-06-03 AT AT97925987T patent/ATE205836T1/de not_active IP Right Cessation
- 1997-06-18 ZA ZA9705380A patent/ZA975380B/xx unknown
- 1997-06-20 AR ARP970102715A patent/AR008614A1/es unknown
-
1998
- 1998-02-20 NO NO980718A patent/NO980718L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE69706823T2 (de) | 2002-04-11 |
EA199800215A1 (ru) | 1998-08-27 |
IL123124A0 (en) | 1998-09-24 |
EP0853616B1 (en) | 2001-09-19 |
AU3094197A (en) | 1998-01-14 |
HUP9902026A2 (hu) | 2000-04-28 |
KR19990043993A (ko) | 1999-06-25 |
CN1198158A (zh) | 1998-11-04 |
ES2165061T3 (es) | 2002-03-01 |
DE69706823D1 (en) | 2001-10-25 |
MX9801408A (es) | 1998-05-31 |
AR008614A1 (es) | 2000-02-09 |
EP0853616A1 (en) | 1998-07-22 |
NO980718D0 (no) | 1998-02-20 |
PL325122A1 (en) | 1998-07-06 |
US6057326A (en) | 2000-05-02 |
GB9613021D0 (en) | 1996-08-28 |
CA2228492A1 (en) | 1997-12-31 |
ZA975380B (en) | 1998-01-05 |
WO1997049689A1 (en) | 1997-12-31 |
HUP9902026A3 (en) | 2000-07-28 |
ATE205836T1 (de) | 2001-10-15 |
NO980718L (no) | 1998-04-08 |
CA2228492C (en) | 2007-05-08 |
JPH11511761A (ja) | 1999-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1117659E (pt) | Cianoquinolinas substituidas como inibidores de tirosina-quinases de proteinas | |
CY2008015I1 (el) | Δικυκλικες ετepοαρωματικες ενωσεις σαν αναστολεις πρωτεϊνης κινασης τυροσινης | |
HUS1700048I1 (hu) | Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai | |
NO990123D0 (no) | Bicykliske heteroaromatiske forbindelser som protein-tyrosin-kinase-inhibitorer | |
NO990124D0 (no) | Bicykliske heteroaromatiske forbindelser som protein-tyrosin-kinase-inhibitorer | |
BR9700850A (pt) | Derivados de quinazolina substituídos | |
BR9702328A (pt) | Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina | |
PT912559E (pt) | Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase | |
NO992524D0 (no) | Konsenserte bicykliske pyrimidin-derivater | |
DZ3223A1 (fr) | Inhibiteurs de tyrosine kinases | |
PT946512E (pt) | Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos | |
HUP9901155A3 (en) | Quinazoline derivatives as vegf inhibitors | |
DE69705112T2 (de) | Coralynanaloge als topoisomerase inhibitoren | |
MX9204425A (es) | Derivados de quinazolina como inhibidores de la acetilcolinesterasa. | |
PT858452E (pt) | Derivado tiazol como inibidor da proteina-quinase c | |
PT922034E (pt) | Derivados tetra-hidroquinolina como antagonistas de eaa | |
PT1023268E (pt) | Isoquinolinas como inibidores de uroquinase | |
BR9611504A (pt) | Derivados de quinolina como inibidores de fosfodiesterase do tipo iv | |
GB9600997D0 (en) | N-indolinyl-pyridopyrimidines as tyrosine kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |